ATE497782T1 - Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie - Google Patents

Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Info

Publication number
ATE497782T1
ATE497782T1 AT05735623T AT05735623T ATE497782T1 AT E497782 T1 ATE497782 T1 AT E497782T1 AT 05735623 T AT05735623 T AT 05735623T AT 05735623 T AT05735623 T AT 05735623T AT E497782 T1 ATE497782 T1 AT E497782T1
Authority
AT
Austria
Prior art keywords
gluten
egg yolk
zoeliacia
treating
yolk antibodies
Prior art date
Application number
AT05735623T
Other languages
English (en)
Inventor
Hoon Sunwoo
Jeong S Sim
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE497782T1 publication Critical patent/ATE497782T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05735623T 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie ATE497782T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52139404P 2004-04-16 2004-04-16
PCT/CA2005/000593 WO2005099753A1 (en) 2004-04-16 2005-04-18 Anti-gluten egg yolk antibodies for the treatment of celiac disease

Publications (1)

Publication Number Publication Date
ATE497782T1 true ATE497782T1 (de) 2011-02-15

Family

ID=35149778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05735623T ATE497782T1 (de) 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Country Status (6)

Country Link
US (1) US7854942B2 (de)
EP (1) EP1765395B1 (de)
AT (1) ATE497782T1 (de)
CA (1) CA2561800C (de)
DE (1) DE602005026287D1 (de)
WO (1) WO2005099753A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
EP1948201A4 (de) 2005-11-14 2013-12-25 Valorisation Recherche Ltd Partnership Pharmazeutische zusammensetzungen mit polymer-bindemitteln mit nicht-hydrolysierbaren kovalenten bindungen und ihre verwendung bei der behandlung von zöliakie
US8802094B2 (en) * 2006-10-25 2014-08-12 Wisconsin Alumni Research Foundation Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
EP2215474A4 (de) 2007-07-16 2012-07-18 Avaxia Biologics Inc Antikörpertherapie zur modulation der funktion von darmrezeptoren
EP2725035A1 (de) 2007-10-02 2014-04-30 Avaxia Biologics, Inc. Antikörpertherapie zur Verwendung im Verdauungstrakt
TWI495477B (zh) * 2010-08-03 2015-08-11 Asia Hepato Gene Co 治療肝炎病毒感染的組合物及方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
JP6652353B2 (ja) * 2015-09-09 2020-02-19 任天堂株式会社 通信装置および電池蓋
BR112018010629A2 (pt) * 2015-11-27 2018-11-27 Ericsson Telefon Ab L M método e transmissor ofdm para transmissões multiprotocolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4357272A (en) 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US5849349A (en) 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US4748018A (en) 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
ES2052496T3 (es) 1985-11-25 1994-07-16 Ghen Corp Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
NZ335170A (en) 1996-10-02 2001-08-31 Ovimmune Inc Oral administration of chicken yolk Ig-gamma antibodies to treat disease
EP0905518A1 (de) * 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
GB9814892D0 (en) * 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof

Also Published As

Publication number Publication date
US7854942B2 (en) 2010-12-21
CA2561800A1 (en) 2005-10-27
US20080003263A1 (en) 2008-01-03
EP1765395A4 (de) 2008-06-18
CA2561800C (en) 2011-10-18
WO2005099753A1 (en) 2005-10-27
EP1765395B1 (de) 2011-02-09
EP1765395A1 (de) 2007-03-28
DE602005026287D1 (de) 2011-03-24

Similar Documents

Publication Publication Date Title
Ahmed et al. Enzymatic crosslinking and food allergenicity: A comprehensive review
ATE478567T1 (de) Babynahrung mit hydrolisierten proteinen
He et al. Enzymatic hydrolysis optimization of Paphia undulata and lymphocyte proliferation activity of the isolated peptide fractions
Strixner et al. Egg proteins
ATE497782T1 (de) Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
CY1121332T1 (el) Μiμhtiκα καλσιτονινης προς θεραπεια ασθενειων και διαταραχων
Sung et al. Allergenicity of an enzymatic hydrolysate of soybean 2S protein
WO2009034315A3 (en) Vaccine
US11291221B2 (en) Methods for determination of bioactivity, quantity, removal, or inactivation of cereal amylase trypsin inhibitors in cereals, flours, plants, and complex foods
NZ591649A (en) Emulsified foods comprising a canola protein isolate
ATE356878T1 (de) Herstellung von proteinen in eiern
EA200100668A1 (ru) Индуцируемые пищей, антисекреторные белки в яичном желтке
Román‐Carrasco et al. Bos d 13, A Novel Heat‐Stable Beef Allergen
JP2014171424A (ja) オボムコイドアレルゲンを選択的に低減化した卵白素材の製造方法
BR0110394A (pt) Proteìna anti-congelamento, sequência nucleica, vetor, método para produzir uma proteìna anti-congelamento, organismo geneticamente modificado, extrato contendo proteìna, e, produto alimentìcio
WO2006049756A3 (en) Process for retaining moisture in cooked food with peptide
BR112012031703A2 (pt) materiais proteicos de ovo e lipídocos de ovo isolados, e , métodos para a produção dos mesmos
HK1258012A1 (zh) 新型蛋白质及检测方法
Bupebayeva et al. The Effect of Non-enzymatic Glycosylation on the Physicochemical Properties and Immunoreactivity of Chicken Egg Ovomucoid.
Kondo et al. Comparison of allergenic properties of salmon (Oncorhynchus nerka) between landlocked and anadromous species
Simonato et al. Potential allergens in durum wheat semolina and pasta: fate during cooking and digestion
WO2007130285A3 (en) Process for thickening food having reduced oil and fat content
Liu et al. Allergenicity Reduction of Shrimp (Penaeus vannamei) via Fucoidan-Mediated Covalent Modification: Insights from Epitope Modifying Effect
Mine et al. Genetic attachment of undecane peptides to ovomucoid third domain can suppress the production of specific IgG and IgE antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1765395

Country of ref document: EP